Anders Månsson
Board member
Education
BSc & MBA
Born
1967
Shareholding
10,000 shares
Independent
Yes
Assumed
Board member since 2018
Professional experience
With more than 30 years of experience in the pharmaceutical industry, Anders has held several leading positions in multinational pharmaceutical companies, both abroad and in Sweden. He is currently CEO of Oncoinvent, a Norwegian biotechnology company active in radiopharmaceuticals. He is also a board member of Immetric AB, a private seed capital company that works with investments in early-stage technology-based private companies.
